Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLAD: Glucocorticoids in Acute Type A Aortic Dissection
NCT05329740Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Feb 2022
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of methylprednisolone injection in Acute Type A Aortic Dissection (ATAAD) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Amplitude of variation of Sequential Organ Failure Assessment score at 4 days. Started Feb 2022; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
Acute Type A Aortic Dissection (ATAAD)
Beyond the preview
Go deeper on NCT05329740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05329740.